Valuation : Medpace Holdings, Inc.

Market Cap 16.49B 14.18B 13.34B 12.17B 22.72B 1,564B 22.84B 158B 61.15B 799B 61.93B 60.58B 2,543B P/E 2026 *
33.6x
P/E 2027 * 30.8x
Enterprise Value 15.69B 13.49B 12.69B 11.58B 21.61B 1,488B 21.73B 150B 58.18B 760B 58.92B 57.63B 2,419B EV / Sales 2026 *
5.5x
EV / Sales 2027 * 5.03x
Free-Float
80.34%
Yield 2026 *
-
Yield 2027 * -
1 day-1.20%
1 week-1.86%
Current month-2.02%
1 month-3.39%
3 months+24.68%
6 months+21.62%
Current year+3.62%
1 week 578.16
Extreme 578.16
599.25
1 month 571.01
Extreme 571.01
629.69
Current year 373
Extreme 373
677.9
1 year 373
Extreme 373
677.9
3 years 227.21
Extreme 227.21
677.9
5 years 126.94
Extreme 126.945
677.9
10 years 21.76
Extreme 21.76
677.9
Manager TitleAgeSince
Chief Executive Officer 69 01/07/1992
Director of Finance/CFO 51 01/08/2021
Chief Tech/Sci/R&D Officer 65 01/09/2017
Director TitleAgeSince
Chairman 69 01/07/1992
Director/Board Member 55 01/07/2016
Director/Board Member 72 01/07/2016
Date Insider Type Main position Quantity % Market Cap. Importance
27/08/26 Sell

Chief Executive Officer

-650 0.0023%
26/08/26 Exercice

Director

11,574 0.0415%
26/08/26 Sell

Chief Executive Officer

-4,000 0.0143%
Change 5-day change 1-year change 3-year change Capi.($)
-0.85%-1.86%+19.85%+108.34% 16.49B
-2.75%-7.30%-4.86%+11.00% 48.01B
+1.07%+0.07%+411.42%+536.98% 44.44B
-1.22%-3.03%+34.91%+18.82% 42.67B
-0.65%-3.42%-0.50%+66.98% 39.96B
0.00%-2.61%+13.09%+42.33% 32.75B
-2.35%-1.26% - - 17.74B
-0.37%-2.53%+10.91%+30.93% 14.38B
-0.63%-4.84%+76.42%+39.06% 13.4B
+2.21%+0.30%-5.10%-37.24% 12.22B
Average -0.67%-0.67%+61.80%+90.80% 28.21B
Weighted average by Cap. -0.82%-1.14%+80.94%+119.39%

Financials

2026 *2027 *
Net sales 2.85B 2.45B 2.31B 2.11B 3.93B 270B 3.95B 27.33B 10.57B 138B 10.71B 10.47B 440B 3.03B 2.6B 2.45B 2.23B 4.17B 287B 4.19B 29.01B 11.22B 147B 11.37B 11.12B 467B
Net income 503M 432M 407M 371M 692M 47.64B 696M 4.82B 1.86B 24.35B 1.89B 1.85B 77.49B 547M 470M 442M 403M 753M 51.82B 757M 5.24B 2.03B 26.49B 2.05B 2.01B 84.28B
Net Debt -802M -690M -649M -592M -1.11B -76.06B -1.11B -7.69B -2.97B -38.88B -3.01B -2.95B -124B -1.25B -1.08B -1.01B -924M -1.72B -119B -1.73B -12B -4.64B -60.68B -4.7B -4.6B -193B
Logo Medpace Holdings, Inc.
Medpace Holdings, Inc. is a scientifically driven, global, full-service clinical contract research organization (CRO) providing phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company's operations are principally based in North America, Europe, and Asia.
Employees
6,500
Date Price Change Volume
09/09/26 $581.99 -1.51% 34,039
08/09/26 $590.89 -0.07% 185,218
04/09/26 $591.29 -0.35% 146,430
03/09/26 $593.39 +0.06% 143,232
02/09/26 $593.02 +1.68% 204,197
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
13
Last Close Price
590.89USD
Average target price
581.83USD
Spread / Average Target
-1.53%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MEDP Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!